Ocugen, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY September 30, 2023 | FY June 30, 2023 |
|---|---|---|---|---|---|
| Revenue | $4.4M | $4.1M | $6.0M | — | — |
| Operating income | -$62.9M | -$54.8M | -$65.5M | — | — |
| Operating expenses | $67.3M | $58.8M | $71.6M | — | — |
| Cash from operations | -$57.0M | -$42.1M | -$62.1M | — | — |
| Capital expenditure | $185,000 | $3.4M | $10.5M | — | — |
| Free cash flow | -$57.1M | -$45.5M | -$72.5M | — | — |
| Total assets | $43.5M | $82.4M | $64.5M | $74.7M | $89.0M |
| Total liabilities | $55.7M | $52.8M | $24.0M | $24.9M | $29.7M |
| Total debt | $31.5M | $32.5M | — | — | — |
Shares outstanding 338.5M · Free float 99.1%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.